<p>This poster was presented by Dr. Owens and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.</p>
<p>This overview is provided by Dr. Steve Feldman.</p>

This poster was presented by Dr. Owens and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Steve Feldman.

Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators

Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice.

Share Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators

Sign up to save your podcasts

Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators

Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators

More shows like Research Developments in Atopic Dermatitis

Derms and Conditions